SCHEMBL21269999

SCHEMBL21269999

CC(C)(C)C(C(=O)O)C(=O)O.[LiH]

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MAPT P10636 1/20 0.38
PTGS1 P23219 1/20 0.38
TSHR P16473 2/20 0.37
TP53 P04637 1/20 0.37
SLC7A5 Q01650 1/20 0.36
LMNA P02545 1/20 0.32
THRB P10828 1/20 0.32
RECQL P46063 1/20 0.32
HMGCR P04035 1/20 0.30
CHRM1 P11229 1/20 0.30
TBXA2R P21731 1/20 0.30
ADRA1A P35348 1/20 0.30
ABCB11 O95342 1/20 0.30
F2 P00734 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL897666 0.97 ALDH1A1 (0.39) ALDH1A1MAPTPTGS1TSHRTP53
Methyl Alcohol SCHEMBL28215181 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
Magnesium SCHEMBL29455973 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
Magnesium SCHEMBL7958509 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
SCHEMBL28314602 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
SCHEMBL28315607 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
SCHEMBL21269846 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
SCHEMBL21268936 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
SCHEMBL8110260 0.93 ALDH1A1 (0.38) ALDH1A1MAPTPTGS1TSHRTP53
SCHEMBL28315786 0.90 ALDH1A1 (0.36) ALDH1A1MAPTPTGS1TSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110172019-A The metal salt of malonic acid as the nucleating additive for crystalline thermoplastic 印度石油有限公司 2019-08-27 CN claimed
US-20190256683-A1 METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS INDIAN OIL CORPORATION LIMITED (IN) 2019-08-22 US claimed
EP-3527616-A1 METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS INDIAN OIL CORPORATION Ltd. (IN) 2019-08-21 EP claimed
EP-3527616-B1 METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS INDIAN OIL CORP LTD (IN) 2024-02-07 EP disclosed
CN-110172019-B Metal salts of malonic acid as nucleating additives for crystalline thermoplastics 印度石油有限公司 2022-03-04 CN disclosed
US-11180630-B2 Metal salts of malonic acid as nucleating additives for crystalline thermoplastics INDIAN OIL CORPORATION LIMITED (IN) 2021-11-23 US disclosed
CN-110172019-A The metal salt of malonic acid as the nucleating additive for crystalline thermoplastic 印度石油有限公司 2019-08-27 CN disclosed
US-20190256683-A1 METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS INDIAN OIL CORPORATION LIMITED (IN) 2019-08-22 US disclosed
EP-3527616-A1 METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS INDIAN OIL CORPORATION Ltd. (IN) 2019-08-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190256683-A1 METAL SALTS OF MALONIC ACID AS NUCLEATING ADDITIVES FOR CRYSTALLINE THERMOPLASTICS NUMA1, MNS1, ME1 ALDH1A1 727/4885MAPT 337/4885PTGS1 2200/4885
US-11180630-B2 Metal salts of malonic acid as nucleating additives for crystalline thermoplastics NUMA1, MNS1, ME1 ALDH1A1 727/4885MAPT 337/4885PTGS1 2200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.